Buy or sell Bolt Biotherapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

View More Companies

Bolt Biotherapeutics Stock

Bolt Therapeutics plans to develop a novel format for T-cell mediated anti-tumour therapy.

About Bolt Biotherapeutics Stock

Bolt Therapeutics plans to develop a novel format for T-cell mediated anti-tumour therapy.

Funding History

March 2015$600K
September 2016$10.0M
August 2018$19.4M
February 2019$54.0M

Management

President and CEO

Reiner Laus

Chief Business Officer

Grant Yonehiro

Chief Executive Officer and Director

CP Liu

Founder

Edgar Engleman

Other Companies

Cartiva Logo
Learn More
Learn More
Cartiva
Cartiva is a developer of innovative products for the treatment of cartilage injuries and osteoarthritis.
$24.3MTotal Funding
Insitro Logo
Learn More
Learn More
Insitro
Insitro is revolutionizing pharmaceutical R&D by leveraging machine learning for drug discovery.
$0Total Funding
Seven Bridges Logo
Learn More
Learn More
Seven Bridges
Seven Bridges is the leading biomedical data science company.
$98.0MTotal Funding
ZSX Medical Logo
Learn More
Learn More
ZSX Medical
ZSX Medical, LLC, is a pre-clinical stage medical device company.
$2.3MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Bolt Biotherapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo